Godrej Agrovet Q1 Results: Animal Nutrition EBIT up 30%, Crop Care down
Godrej Agrovet's Q1FY27 results reflect a strategic shift towards value creation with mixed segmental outcomes. Animal Nutrition and Oil Palm posted significant growth, while Crop Care faced challenges due to weather delays. The company is streamlining its portfolio, focusing on high-margin businesses, and launching new products to drive future growth.

*this image is generated using AI for illustrative purposes only.
Godrej Agrovet reported Q1FY27 results on August 5, 2026, highlighting a strategic pivot toward value creation amid mixed segmental performance. The Board of Directors approved the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. While the company faced transient cost pressures and weather-related headwinds, it delivered resilient topline growth in key segments. Management emphasized a structural reset to streamline the complex portfolio, shift from a commodity mindset to customer-facing capabilities, and focus capital allocation on high-return businesses.
The Animal Nutrition business in India demonstrated robust growth, with cattle feed volumes rising approximately 15% year-on-year. This volume expansion, driven by strong demand and improved realizations, contributed to a material improvement in margin performance. Underlying segment results improved by roughly 36% year-on-year, reflecting benefits from strategic commodity sourcing, operating leverage, and cost discipline. In Bangladesh, the joint venture ACI Godrej Agrovet also returned to a growth trajectory, with profit before tax increasing by 12% year-on-year due to operational leverage and volume growth.
Segment Performance Highlights
| Segment | Key Metric | Change/Status |
|---|---|---|
| Animal Nutrition (India) | Cattle Feed Volume | +15% YoY |
| Animal Nutrition (India) | Underlying Segment Results | +36% YoY |
| Oil Palm Business | EBIT Growth | +14% |
| Oil Palm Business | Volume Growth | +9% |
| Godrej Foods | Yummiez Volume Growth | +22% |
| Creamline Dairy | Revenue Growth | +11% |
| Creamline Dairy | Volume Growth | +8% |
| Crop Care Business | Revenue Impact | De-growth (~17%) |
| Astec LifeSciences | EBITDA | Break-even continued |
The Oil Palm Business saw a 43 basis points growth in Oil Extraction Ratio (OER) and a 14% increase in EBIT. Fresh fruit bunch volumes remained broadly flat compared to a high-comparable base in Q1FY26. Excluding trading revenues of ₹ 29 crore in Q1FY27 (compared to ₹ 41 crore in Q1FY26), segment revenue was driven by improved realizations and higher sales volumes.
Conversely, the Crop Care Business experienced de-growth in revenue, estimated at approximately 17%, primarily due to lower volumes of in-house cotton herbicides. Demand remained muted amid a significantly delayed monsoon and slower kharif sowings following one of the driest Junes in over a decade. However, new launches such as Ashitaka (Maize Herbicide) and Takai (Paddy insecticide) gained market traction, with Ashitaka volumes scaling threefold to 30 kL in Q1FY27.
Strategic Reset and Portfolio Streamlining
Management outlined a plan to build multiple pillars of growth within each business while reducing exposure to unprofitable or sub-scale segments. The company identified specific businesses for strategic review, including Shrimp Feed, and plans to close live bird trading. Capital expenditure is expected to continue at ₹ 300 – 350 crore per year, funded through internal accruals, with a majority allocated to high-margin, high ROCE businesses. The company also emphasized sharp focus on managing Net Working Capital to improve Return on Capital Employed (ROCE).
What the Numbers Show
A notable divergence exists between the operational performance of ACI Godrej Agrovet and its bottom-line impact. While Profit Before Tax increased by 12% year-on-year due to operational leverage, Profit After Tax declined. This decline was primarily driven by a higher effective tax rate following a change in the applicable tax rate from 15% to 27.5% effective July 1, 2025. This indicates that the dip in net profitability was regulatory rather than operational, preserving the integrity of the underlying business recovery.
Godrej Foods Ltd. maintained stable revenues despite a deliberate reduction in live bird volumes, supported by a 22% volume growth in the Yummiez brand. Approximately 20% of GFL’s B2C revenue in Q1FY27 came from new product developments across frozen chicken, momos, and nuggets. Creamline Dairy saw revenue grow by 11%, driven by strong volume growth in value-added products, although EBITDA was impacted by elevated milk procurement prices and inflationary pressures.
Historical Stock Returns for Godrej Agrovet
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.57% | -1.85% | -0.29% | +1.43% | -30.19% | -20.52% |
How will the strategic exit from live bird trading and the review of the Shrimp Feed business impact Godrej Agrovet's overall revenue mix and short-term profitability?
What specific operational levers is management planning to deploy to offset the impact of elevated milk procurement costs on Creamline Dairy's EBITDA margins?
Will the successful scaling of new Crop Care launches like Ashitaka be sufficient to reverse the segment's revenue de-growth trend in Q2FY27 despite ongoing monsoon delays?


































